/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sosipatros A. Boikos

Georgetown University Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

216

Papers

5.1K

Citations

38

h-index

55

i10-index

Sosipatros A. Boikos is an academic researcher from Georgetown University Medical Center. The author has contributed to research in topics: RNA modifications and cancer & Sarcoma Diagnosis and Treatment & Protein Tyrosine Phosphatases. The author has an h-index of 38, co-authored 184 publications.

ORCID: 0000-0002-8608-6962

Research Topics

RNA modifications and cancer Sarcoma Diagnosis and Treatment Protein Tyrosine Phosphatases PARP inhibition in cancer therapy Neuroblastoma Research and Treatments

Papers by this author

works

Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (<i>PRKAR1A</i>): Phenotype Analysis in 353 Patients and 80 Different Genotypes

2009 · The Journal of Clinical Endocrinology & Metabolism · 432 citations

https://doi.org/10.1210/jc.2008-2333

Jérôme Bertherat Anélia Horvath Lionel Groussin Sophie Grabar

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia

2006 · Nature Genetics · 342 citations

https://doi.org/10.1038/ng1809

Anélia Horvath Sosipatros A. Boikos Christoforos Giatzakis Audrey Robinson‐White

Coamplification of <i>miR-4728</i> protects <i>HER2</i> -amplified breast cancers from targeted therapy

2018 · Proceedings of the National Academy of Sciences · 30 citations

https://doi.org/10.1073/pnas.1717820115

Konstantinos V. Floros Timothy L. Lochmann Bin Hu Carles Monterrubio

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors

2021 · Cell Death and Disease · 18 citations

https://doi.org/10.1038/s41419-021-03457-6

Konstantinos V. Floros Sheeba Jacob Richard Kurupi Carter K. Fairchild

High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition

2022 · Cell Reports · 17 citations

https://doi.org/10.1016/j.celrep.2022.111095

Jinyang Cai Sheeba Jacob Richard Kurupi Krista M. Dalton

Intimal sarcoma of the pulmonary artery treated with neoadjuvant radiation prior to pulmonary artery resection and reconstruction

2021 · Respiratory Medicine Case Reports · 7 citations

https://doi.org/10.1016/j.rmcr.2021.101414

A. J. Allen Steven C. Smith Raghavendra Pillappa Sosipatros A. Boikos

Research topics

topics

RNA modifications and cancer

Sarcoma Diagnosis and Treatment

Protein Tyrosine Phosphatases

PARP inhibition in cancer therapy

Neuroblastoma Research and Treatments

Chat about Author

Papers

Chat

Click to start Chat